Tenaya Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	338	221	83	782
Market Cap Growth	-	165.36%	-89.37%	-
Enterprise Value	246	128	-88	547
PE Ratio	-1.78	-1.78	-0.67	-10.76
PB Ratio	2.43	1.58	0.34	2.81
P/FCF Ratio	-2.14	-2.14	-0.67	-9.10
P/OCF Ratio	-2.16	-2.16	-0.80	-12.86
EV/EBITDA Ratio	-1.14	-1.14	0.77	-7.96
EV/EBIT Ratio	-1.04	-1.04	0.71	-7.52
EV/FCF Ratio	-1.24	-1.24	0.71	-6.36
Debt / Equity Ratio	0.09	0.09	0.06	0.06
Debt / EBITDA Ratio	-0.11	-0.11	-0.13	-0.23
Debt / FCF Ratio	-0.12	-0.12	-0.12	-0.18
Quick Ratio	4.60	4.60	7.69	11.54
Current Ratio	4.91	4.91	7.99	11.73
Return on Equity (ROE)	-69.90%	-69.90%	-54.20%	-76.60%
Return on Assets (ROA)	-59.80%	-59.80%	-47.40%	-30.20%
Return on Capital (ROIC)	-86.40%	-86.40%	-48.60%	-24.74%
Earnings Yield	-36.67%	-56.23%	-148.70%	-9.30%
FCF Yield	-30.53%	-46.81%	-150.37%	-10.98%
Buyback Yield / Dilution	-64.61%	-64.61%	-152.75%	-1724.33%
Total Shareholder Return	-64.61%	-64.61%	-152.75%	-1724.33%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).